Hepatic lipase gene polymorphism, pre-pregnancy overweight status and risk of preeclampsia among Peruvian women

Gynecological Endocrinology

Volumn 21, Issue 4, 2005, Pages 211-217

  Enquobahrie, Daniel A ^a,b,c   Sanchez, Sixto E ^d   Muy Rivera, Martin ^a   Qiu, Chunfang ^a   Zhang, Cuilin ^f   Austin, Melissa A ^b,e   Williams, Michelle A ^a,b  

^a SWEDISH MEDICAL CENTER   (United States)

^b Department of Epidemiology ^*  (Peru)

^c Cardiovascular Health Research Unit   (Peru)

^d HOSPITAL NACIONAL DOS DE MAYO   (Peru)

^e UNIVERSITY OF WASHINGTON   (United States)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Body mass index; Hepatic lipase gene; Polymorphism; Preeclampsia

Indexed keywords

LIVER ENZYME; TRIACYLGLYCEROL LIPASE;

ARTICLE; BODY MASS; CALCULATION; CASE CONTROL STUDY; CLINICAL EXAMINATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GEL ELECTROPHORESIS; GENOTYPE; HEALTH STATUS; HUMAN; LOGISTIC REGRESSION ANALYSIS; MATERNAL AGE; OBESITY; PARITY; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT;

BODY MASS INDEX; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; GENOTYPE; HUMANS; LIPASE; LOGISTIC MODELS; OBESITY; ODDS RATIO; PERU; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PRECONCEPTION CARE; PREGNANCY; RISK FACTORS;

EID: 28844448688     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590500279626     Document Type: Article

References (39)

1. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003;41:437-445.
2. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998;179:1359-1375.
3. Wilson ML, Goodwin TM, Pan VL, Ingles SA. Molecular epidemiology of preeclampsia. Obstet Gynecol Surv 2003;58:39-66.
4. Lachmeijer AM, Dekker GA, Pals G, Aarnoudse JG, ten Kate LP, Arngrimsson R. Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 2002;105:94-113.
5. Lorentzen BH. Plasma lipids and vascular dysfunction in preeclampsia. Sem in Reproductive Endocrinology 1998;16:33-39.
6. Enquobahrie DA, Williams MA, Butler CL, Frederick IO, Miller RS, Luthy DA. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 2004;17:574-581.
7. Ware-Jauregui S, Sanchez SE, Zhang C, Laraburre G, King IB, Williams MA. Plasma lipid concentrations in pre-elcamptic and normotensive Peruvian women. Int J Gynaecol Obstet 1999;67:147-155.
8. Sparkes RS, Zollman S, Klisak I, Kuchgessner TG, Komaromy MC, Mohandas T, Schotz MC, Lusis AJ. Human genes involved in lipolysis of plasma lipoproteins; mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21. Genomics 1987;1:138-144.
9. Ameis D, Stahnke G, Kobayashi J, McLean J, Lee G, Buscher M, Schotz MC, Will H. Isolation and characterization of the human hepatic lipase gene. J Biol Chem 1990;265:6552-6555.
10. Cai SJ, Wong DM, Chen SH, Chan L. Structure of the human hepatic triglyceride lipase gene. Biochemistry 1989;28:8966-8971.
11. Jansen H, Verhoeven AJ, Sijbrands EJ. Hepatic lipase: a pro-or anti-atherogenic protein? J Lipid Res 2002;43:1352-1362.
12. Rizzo M, Taylor JM, Barbagallo CM, Berneis K, Blanche PJ, Krauss RM. Effects on lipoprotein subclasses of combined expression of human hepatic lipase and human apoB in transgenic rabbits. Arterioscler Thromb Vasc Biol 2004;24:141-146.
13. Andersen RV, Wittrup HH, Tybjaerg-Hansen A, Steffensen R, Schnohr P, Nordestgaard BG. Hepatic lipase mutations, elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study. J Am Coll Cardiol 2003;41:1972-1982.
14. Juo SH, Han Z, Smith JD, Colangelo L, Liu K. Promoter polymorphisms of hepatic lipase gene influence HDL(2) but not HDL(3) in African American men: CARDIA study. J Lipid Res 2001;42:258-264.
15. Guerra R, Wang J, Grundy SM, Cohen JC. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A 1997;94:4532-4537.
16. van't Hooft FM, Lundahl B, Ragogna F, Karpe F, Olivecrona G, Hamsten A. Functional characterization of 4 polymorphisms in promoter region of hepatic lipase gene. Arterioscler Thromb Vasc Biol 2000;20:1335-1339.
17. Zambon A, Deeb SS, Pauletto P, Crepaldi G, Brunzell JD. Hepatic lipase: a marker for cardiovascular disease risk and response to therapy. Curr Opin Lipidol 2003;14:179-189.
18. Tahvanainen E, Syvanne M, Frick HM, Murtomaki-Repo S, Antikainen M, Kesaniemi A, Kauma H, Pasternak A, Taskinen M, Ehnholm C. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. J Clin Invest 1998;101:956-960.
19. Pihlajamaki J, Karjalainen L, Karhapaa P, Vauhkonen I, Taskinen MR, Deeb SS, Laakso M. G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2000;20:1789-1795.
20. Su Z, Zhang S, Nebert DW, Zhang L, Huang D, Hou Y, Liao L, Xiao C. A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity. J Lipid Res 2002;43:1595-1601.
21. Hegele RA, Harris S, Brunt JH, Young TK, Hanley AJ, Zinman B, Connelly PW. Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis 1999;146:153-160.
22. Connelly PW, Hegele RA. Hepatic lipase deficiency. Crit Rev Clin Lab Sci 1998;35:547-572.
23. Deeb SS, Zambon A, Carr MC, Ayyobi AF, Brunzell JD. Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. J Lipid Res 2003;44:1279-1286.
24. Nie L, Wang J, Clark LT, Tang A, Vega GL, Grundy SM, Cohen JC. Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J Lipid Res 1998;39:1127-1130.
25. Muy-Rivera M, Sanchez SE, Vadachkoria S, Qiu C, Bazul V, Williams MA. Transforming growth factor-betal (TGF-beta1) in plasma is associated with preeclampsia risk in Peruvian women with systemic inflammation. Am J Hypertens 2004;17:334-338.
26. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. ACOG Technical Bulletin 1996;219:1-8.
27. Somekawa Y, Umeki H, Kobayashi K, Tomura S, Aso T, Hamaguchi H. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women. J Clin Endocrino Metab 2002;87:4766-4770.
28. Hokanson JE, Kamboh MI, Scarboro S, Eckel RH, Hamman RF. Effects of Hepatic Lipase Gene and Physical Activity on Coronary Heart Disease Risk. Am J Epidemiol 2003;158:836-843.
29. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia: Lippincott-Raven Publishers; 1998. p 253-258.
30. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
31. Couture P, Otvos JD, Cupples LA, Lahoz C, Wilson PWF, Schaefer EJ, Ordovas JM. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles. Arterioscler Thromb 2000;20:815-822.
32. Jansen H, Waterworth DM, Nicaud V, Ehnholm C, Talmud PJ. Interaction of the common apolipoprotein C-III (APOC3 -482C > T) and hepatic lipase (LIPC 514C > T) promoter variants affects glucose tolerance in young adult. European Atherosclerosis Research Study II (EARS-11). Ann Hum Genet 2001;65:237-243.
33. Clay MA, Newnham HH, Forte TM, Barter PI. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta 1992;1124:52-58.
34. Carr MC, Hokanson JE, Deeb SS, Purnell JQ, Mitchell ES, Brunzell JD. A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women. Arterioscler Thromb Vasc Biol 1999;19:2701-2707.
35. Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab 2003;88:2393-2398.
36. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75:473-486.
37. Cales-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 2001;22:36-52.
38. Cominacini L, Garbin U, Davoli A, Campagnola M, De Santis A, Pasini C, Pastorino AM, Bosello O. High-denisity lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases in obesity: relationships with plasma insulin levels. Ann Nutr Metab 1993;37:175-184.
39. Simonen PP, Gylling H, Miettinen TA. Body weight modulates cholesterol metabolism in Non-insulin dependent type 2 diabetics. Obes Res 2002;10:328-335.